Pharma & Healthcare
Global Veterinary Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 298097
- Pages: 199
- Figures: 188
- Views: 60
In 2024, the global market size of Veterinary Vaccine was estimated to be worth US$ 12390 million and is forecast to reach approximately US$ 19690 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.
North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
Medion
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Segment by Application
Farm Animal
Companion Animal
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.
North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
Medion
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Segment by Application
Farm Animal
Companion Animal
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Veterinary Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Other
1.3 Market by Application
1.3.1 Global Veterinary Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Farm Animal
1.3.3 Companion Animal
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccine Market Size Estimates and Forecasts
2.1.1 Global Veterinary Vaccine Revenue 2020-2031
2.1.2 Global Veterinary Vaccine Sales 2020-2031
2.2 Veterinary Vaccine Market Size by Region: 2024 Versus 2031
2.3 Veterinary Vaccine Sales by Region (2020-2031)
2.3.1 Global Veterinary Vaccine Sales by Region: 2020-2025
2.3.2 Global Veterinary Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Veterinary Vaccine Sales Market Share by Region (2020-2031)
2.4 Veterinary Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Veterinary Vaccine Revenue by Region: 2020-2025
2.4.2 Global Veterinary Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Veterinary Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Veterinary Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Veterinary Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Veterinary Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Veterinary Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Veterinary Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Veterinary Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Veterinary Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Veterinary Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Veterinary Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Veterinary Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Veterinary Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Veterinary Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Veterinary Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Veterinary Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Live Attenuated Vaccines of Veterinary Vaccine Revenue Market Share by Application
3.3.2 Inactivated Vaccines of Veterinary Vaccine Revenue Market Share by Application
3.3.3 Other of Veterinary Vaccine Revenue Market Share by Application
4 Global Veterinary Vaccine by Manufacturers
4.1 Global Top Veterinary Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Veterinary Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Veterinary Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Veterinary Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Veterinary Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Veterinary Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Veterinary Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Veterinary Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Veterinary Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Veterinary Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Veterinary Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Veterinary Vaccine Market
4.5.3 Manufacturers Veterinary Vaccine Product Type and Application
4.5.4 Live Attenuated Vaccines Market Sales of Veterinary Vaccine by Manufacturer
4.5.5 Inactivated Vaccines Market Sales of Veterinary Vaccine by Manufacturer
4.5.6 Other Market Sales of Veterinary Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Veterinary Vaccine Products Offered
5.1.4 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Veterinary Vaccine Sales by Product in 2024
5.1.6 Merck Veterinary Vaccine Sales by Application in 2024
5.1.7 Merck Veterinary Vaccine Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Zoetis
5.2.1 Zoetis Company Information
5.2.2 Zoetis Description, Business Overview
5.2.3 Zoetis Veterinary Vaccine Products Offered
5.2.4 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Zoetis Veterinary Vaccine Sales by Product in 2024
5.2.6 Zoetis Veterinary Vaccine Sales by Application in 2024
5.2.7 Zoetis Veterinary Vaccine Sales by Geographic Area in 2024
5.2.8 Zoetis Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Company Information
5.3.2 Boehringer Ingelheim Description, Business Overview
5.3.3 Boehringer Ingelheim Veterinary Vaccine Products Offered
5.3.4 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Boehringer Ingelheim Veterinary Vaccine Sales by Product in 2024
5.3.6 Boehringer Ingelheim Veterinary Vaccine Sales by Application in 2024
5.3.7 Boehringer Ingelheim Veterinary Vaccine Sales by Geographic Area in 2024
5.3.8 Boehringer Ingelheim Recent Developments
5.4 Ceva
5.4.1 Ceva Company Information
5.4.2 Ceva Description, Business Overview
5.4.3 Ceva Veterinary Vaccine Products Offered
5.4.4 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Ceva Veterinary Vaccine Sales by Product in 2024
5.4.6 Ceva Veterinary Vaccine Sales by Application in 2024
5.4.7 Ceva Veterinary Vaccine Sales by Geographic Area in 2024
5.4.8 Ceva Recent Developments
5.5 CAHIC
5.5.1 CAHIC Company Information
5.5.2 CAHIC Description, Business Overview
5.5.3 CAHIC Veterinary Vaccine Products Offered
5.5.4 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 CAHIC Veterinary Vaccine Sales by Product in 2024
5.5.6 CAHIC Veterinary Vaccine Sales by Application in 2024
5.5.7 CAHIC Veterinary Vaccine Sales by Geographic Area in 2024
5.5.8 CAHIC Recent Developments
5.6 HVRI
5.6.1 HVRI Company Information
5.6.2 HVRI Description, Business Overview
5.6.3 HVRI Veterinary Vaccine Products Offered
5.6.4 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 HVRI Veterinary Vaccine Sales by Product in 2024
5.6.6 HVRI Veterinary Vaccine Sales by Application in 2024
5.6.7 HVRI Veterinary Vaccine Sales by Geographic Area in 2024
5.6.8 HVRI Recent Developments
5.7 Ringpu Biology
5.7.1 Ringpu Biology Company Information
5.7.2 Ringpu Biology Description, Business Overview
5.7.3 Ringpu Biology Veterinary Vaccine Products Offered
5.7.4 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Ringpu Biology Veterinary Vaccine Sales by Product in 2024
5.7.6 Ringpu Biology Veterinary Vaccine Sales by Application in 2024
5.7.7 Ringpu Biology Veterinary Vaccine Sales by Geographic Area in 2024
5.7.8 Ringpu Biology Recent Developments
5.8 Yebio
5.8.1 Yebio Company Information
5.8.2 Yebio Description, Business Overview
5.8.3 Yebio Veterinary Vaccine Products Offered
5.8.4 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Yebio Veterinary Vaccine Sales by Product in 2024
5.8.6 Yebio Veterinary Vaccine Sales by Application in 2024
5.8.7 Yebio Veterinary Vaccine Sales by Geographic Area in 2024
5.8.8 Yebio Recent Developments
5.9 DHN
5.9.1 DHN Company Information
5.9.2 DHN Description, Business Overview
5.9.3 DHN Veterinary Vaccine Products Offered
5.9.4 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 DHN Veterinary Vaccine Sales by Product in 2024
5.9.6 DHN Veterinary Vaccine Sales by Application in 2024
5.9.7 DHN Veterinary Vaccine Sales by Geographic Area in 2024
5.9.8 DHN Recent Developments
5.10 WINSUN
5.10.1 WINSUN Company Information
5.10.2 WINSUN Description, Business Overview
5.10.3 WINSUN Veterinary Vaccine Products Offered
5.10.4 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 WINSUN Veterinary Vaccine Sales by Product in 2024
5.10.6 WINSUN Veterinary Vaccine Sales by Application in 2024
5.10.7 WINSUN Veterinary Vaccine Sales by Geographic Area in 2024
5.10.8 WINSUN Recent Developments
5.11 Elanco
5.11.1 Elanco Company Information
5.11.2 Elanco Description, Business Overview
5.11.3 Elanco Veterinary Vaccine Products Offered
5.11.4 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Elanco Veterinary Vaccine Sales by Product in 2024
5.11.6 Elanco Veterinary Vaccine Sales by Application in 2024
5.11.7 Elanco Veterinary Vaccine Sales by Geographic Area in 2024
5.11.8 Elanco Recent Developments
5.12 Virbac
5.12.1 Virbac Company Information
5.12.2 Virbac Description, Business Overview
5.12.3 Virbac Veterinary Vaccine Products Offered
5.12.4 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Virbac Veterinary Vaccine Sales by Product in 2024
5.12.6 Virbac Veterinary Vaccine Sales by Application in 2024
5.12.7 Virbac Veterinary Vaccine Sales by Geographic Area in 2024
5.12.8 Virbac Recent Developments
5.13 Jinyu Bio-Technology
5.13.1 Jinyu Bio-Technology Company Information
5.13.2 Jinyu Bio-Technology Description, Business Overview
5.13.3 Jinyu Bio-Technology Veterinary Vaccine Products Offered
5.13.4 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Jinyu Bio-Technology Veterinary Vaccine Sales by Product in 2024
5.13.6 Jinyu Bio-Technology Veterinary Vaccine Sales by Application in 2024
5.13.7 Jinyu Bio-Technology Veterinary Vaccine Sales by Geographic Area in 2024
5.13.8 Jinyu Bio-Technology Recent Developments
5.14 Medion
5.14.1 Medion Company Information
5.14.2 Medion Description, Business Overview
5.14.3 Medion Veterinary Vaccine Products Offered
5.14.4 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Medion Veterinary Vaccine Sales by Product in 2024
5.14.6 Medion Veterinary Vaccine Sales by Application in 2024
5.14.7 Medion Veterinary Vaccine Sales by Geographic Area in 2024
5.14.8 Medion Recent Developments
5.15 CAVAC
5.15.1 CAVAC Company Information
5.15.2 CAVAC Description, Business Overview
5.15.3 CAVAC Veterinary Vaccine Products Offered
5.15.4 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.15.5 CAVAC Veterinary Vaccine Sales by Product in 2024
5.15.6 CAVAC Veterinary Vaccine Sales by Application in 2024
5.15.7 CAVAC Veterinary Vaccine Sales by Geographic Area in 2024
5.15.8 CAVAC Recent Developments
5.16 Kyoto Biken Laboratories
5.16.1 Kyoto Biken Laboratories Company Information
5.16.2 Kyoto Biken Laboratories Description, Business Overview
5.16.3 Kyoto Biken Laboratories Veterinary Vaccine Products Offered
5.16.4 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Kyoto Biken Laboratories Veterinary Vaccine Sales by Product in 2024
5.16.6 Kyoto Biken Laboratories Veterinary Vaccine Sales by Application in 2024
5.16.7 Kyoto Biken Laboratories Veterinary Vaccine Sales by Geographic Area in 2024
5.16.8 Kyoto Biken Laboratories Recent Developments
5.17 FATRO
5.17.1 FATRO Company Information
5.17.2 FATRO Description, Business Overview
5.17.3 FATRO Veterinary Vaccine Products Offered
5.17.4 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.17.5 FATRO Veterinary Vaccine Sales by Product in 2024
5.17.6 FATRO Veterinary Vaccine Sales by Application in 2024
5.17.7 FATRO Veterinary Vaccine Sales by Geographic Area in 2024
5.17.8 FATRO Recent Developments
5.18 Vaksindo
5.18.1 Vaksindo Company Information
5.18.2 Vaksindo Description, Business Overview
5.18.3 Vaksindo Veterinary Vaccine Products Offered
5.18.4 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Vaksindo Veterinary Vaccine Sales by Product in 2024
5.18.6 Vaksindo Veterinary Vaccine Sales by Application in 2024
5.18.7 Vaksindo Veterinary Vaccine Sales by Geographic Area in 2024
5.18.8 Vaksindo Recent Developments
5.19 Bio-Labs
5.19.1 Bio-Labs Company Information
5.19.2 Bio-Labs Description, Business Overview
5.19.3 Bio-Labs Veterinary Vaccine Products Offered
5.19.4 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Bio-Labs Veterinary Vaccine Sales by Product in 2024
5.19.6 Bio-Labs Veterinary Vaccine Sales by Application in 2024
5.19.7 Bio-Labs Veterinary Vaccine Sales by Geographic Area in 2024
5.19.8 Bio-Labs Recent Developments
5.20 Avimex Animal Health
5.20.1 Avimex Animal Health Company Information
5.20.2 Avimex Animal Health Description, Business Overview
5.20.3 Avimex Animal Health Veterinary Vaccine Products Offered
5.20.4 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.20.5 Avimex Animal Health Veterinary Vaccine Sales by Product in 2024
5.20.6 Avimex Animal Health Veterinary Vaccine Sales by Application in 2024
5.20.7 Avimex Animal Health Veterinary Vaccine Sales by Geographic Area in 2024
5.20.8 Avimex Animal Health Recent Developments
5.21 MEVAC
5.21.1 MEVAC Company Information
5.21.2 MEVAC Description, Business Overview
5.21.3 MEVAC Veterinary Vaccine Products Offered
5.21.4 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.21.5 MEVAC Veterinary Vaccine Sales by Product in 2024
5.21.6 MEVAC Veterinary Vaccine Sales by Application in 2024
5.21.7 MEVAC Veterinary Vaccine Sales by Geographic Area in 2024
5.21.8 MEVAC Recent Developments
5.22 Biovac
5.22.1 Biovac Company Information
5.22.2 Biovac Description, Business Overview
5.22.3 Biovac Veterinary Vaccine Products Offered
5.22.4 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.22.5 Biovac Veterinary Vaccine Sales by Product in 2024
5.22.6 Biovac Veterinary Vaccine Sales by Application in 2024
5.22.7 Biovac Veterinary Vaccine Sales by Geographic Area in 2024
5.22.8 Biovac Recent Developments
5.23 Atafen
5.23.1 Atafen Company Information
5.23.2 Atafen Description, Business Overview
5.23.3 Atafen Veterinary Vaccine Products Offered
5.23.4 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.23.5 Atafen Veterinary Vaccine Sales by Product in 2024
5.23.6 Atafen Veterinary Vaccine Sales by Application in 2024
5.23.7 Atafen Veterinary Vaccine Sales by Geographic Area in 2024
5.23.8 Atafen Recent Developments
5.24 Dyntec
5.24.1 Dyntec Company Information
5.24.2 Dyntec Description, Business Overview
5.24.3 Dyntec Veterinary Vaccine Products Offered
5.24.4 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.24.5 Dyntec Veterinary Vaccine Sales by Product in 2024
5.24.6 Dyntec Veterinary Vaccine Sales by Application in 2024
5.24.7 Dyntec Veterinary Vaccine Sales by Geographic Area in 2024
5.24.8 Dyntec Recent Developments
5.25 RVSRI
5.25.1 RVSRI Company Information
5.25.2 RVSRI Description, Business Overview
5.25.3 RVSRI Veterinary Vaccine Products Offered
5.25.4 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.25.5 RVSRI Veterinary Vaccine Sales by Product in 2024
5.25.6 RVSRI Veterinary Vaccine Sales by Application in 2024
5.25.7 RVSRI Veterinary Vaccine Sales by Geographic Area in 2024
5.25.8 RVSRI Recent Developments
6 North America
6.1 North America Veterinary Vaccine Market Size YoY Growth 2020-2031
6.2 North America Veterinary Vaccine Market Facts & Figures by Country
6.2.1 North America Veterinary Vaccine Sales by Country (2020-2031)
6.2.2 North America Veterinary Vaccine Revenue by Country (2020-2031)
6.3 North America Veterinary Vaccine Sales by Type (2020-2025)
6.4 North America Veterinary Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Veterinary Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Veterinary Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Veterinary Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Veterinary Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Veterinary Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Veterinary Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Veterinary Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Veterinary Vaccine Market Facts & Figures by Country
8.2.1 Europe Veterinary Vaccine Sales by Country (2020-2031)
8.2.2 Europe Veterinary Vaccine Revenue by Country (2020-2031)
8.3 Europe Veterinary Vaccine Sales by Type (2020-2025)
8.4 Europe Veterinary Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Veterinary Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Veterinary Vaccine Market Facts & Figures by Country
9.2.1 Latin America Veterinary Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Veterinary Vaccine Revenue by Country (2020-2031)
9.3 Latin America Veterinary Vaccine Sales by Type (2020-2025)
9.4 Latin America Veterinary Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Veterinary Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Veterinary Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Veterinary Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Veterinary Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Veterinary Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Veterinary Vaccine Supply Chain Analysis
11.2 Veterinary Vaccine Key Raw Materials and Upstream Suppliers
11.3 Veterinary Vaccine Clients Analysis
11.4 Veterinary Vaccine Sales Channel and Sales Model Analysis
11.4.1 Veterinary Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Veterinary Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Veterinary Vaccine Distributors
12 Veterinary Vaccine Market Dynamics
12.1 Veterinary Vaccine Industry Trends
12.2 Veterinary Vaccine Market Drivers
12.3 Veterinary Vaccine Market Challenges
12.4 Veterinary Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Veterinary Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Other
1.3 Market by Application
1.3.1 Global Veterinary Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Farm Animal
1.3.3 Companion Animal
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccine Market Size Estimates and Forecasts
2.1.1 Global Veterinary Vaccine Revenue 2020-2031
2.1.2 Global Veterinary Vaccine Sales 2020-2031
2.2 Veterinary Vaccine Market Size by Region: 2024 Versus 2031
2.3 Veterinary Vaccine Sales by Region (2020-2031)
2.3.1 Global Veterinary Vaccine Sales by Region: 2020-2025
2.3.2 Global Veterinary Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Veterinary Vaccine Sales Market Share by Region (2020-2031)
2.4 Veterinary Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Veterinary Vaccine Revenue by Region: 2020-2025
2.4.2 Global Veterinary Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Veterinary Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Veterinary Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Veterinary Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Veterinary Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Veterinary Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Veterinary Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Veterinary Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Veterinary Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Veterinary Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Veterinary Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Veterinary Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Veterinary Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Veterinary Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Veterinary Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Veterinary Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Live Attenuated Vaccines of Veterinary Vaccine Revenue Market Share by Application
3.3.2 Inactivated Vaccines of Veterinary Vaccine Revenue Market Share by Application
3.3.3 Other of Veterinary Vaccine Revenue Market Share by Application
4 Global Veterinary Vaccine by Manufacturers
4.1 Global Top Veterinary Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Veterinary Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Veterinary Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Veterinary Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Veterinary Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Veterinary Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Veterinary Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Veterinary Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Veterinary Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Veterinary Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Veterinary Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Veterinary Vaccine Market
4.5.3 Manufacturers Veterinary Vaccine Product Type and Application
4.5.4 Live Attenuated Vaccines Market Sales of Veterinary Vaccine by Manufacturer
4.5.5 Inactivated Vaccines Market Sales of Veterinary Vaccine by Manufacturer
4.5.6 Other Market Sales of Veterinary Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Veterinary Vaccine Products Offered
5.1.4 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Veterinary Vaccine Sales by Product in 2024
5.1.6 Merck Veterinary Vaccine Sales by Application in 2024
5.1.7 Merck Veterinary Vaccine Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Zoetis
5.2.1 Zoetis Company Information
5.2.2 Zoetis Description, Business Overview
5.2.3 Zoetis Veterinary Vaccine Products Offered
5.2.4 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Zoetis Veterinary Vaccine Sales by Product in 2024
5.2.6 Zoetis Veterinary Vaccine Sales by Application in 2024
5.2.7 Zoetis Veterinary Vaccine Sales by Geographic Area in 2024
5.2.8 Zoetis Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Company Information
5.3.2 Boehringer Ingelheim Description, Business Overview
5.3.3 Boehringer Ingelheim Veterinary Vaccine Products Offered
5.3.4 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Boehringer Ingelheim Veterinary Vaccine Sales by Product in 2024
5.3.6 Boehringer Ingelheim Veterinary Vaccine Sales by Application in 2024
5.3.7 Boehringer Ingelheim Veterinary Vaccine Sales by Geographic Area in 2024
5.3.8 Boehringer Ingelheim Recent Developments
5.4 Ceva
5.4.1 Ceva Company Information
5.4.2 Ceva Description, Business Overview
5.4.3 Ceva Veterinary Vaccine Products Offered
5.4.4 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Ceva Veterinary Vaccine Sales by Product in 2024
5.4.6 Ceva Veterinary Vaccine Sales by Application in 2024
5.4.7 Ceva Veterinary Vaccine Sales by Geographic Area in 2024
5.4.8 Ceva Recent Developments
5.5 CAHIC
5.5.1 CAHIC Company Information
5.5.2 CAHIC Description, Business Overview
5.5.3 CAHIC Veterinary Vaccine Products Offered
5.5.4 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 CAHIC Veterinary Vaccine Sales by Product in 2024
5.5.6 CAHIC Veterinary Vaccine Sales by Application in 2024
5.5.7 CAHIC Veterinary Vaccine Sales by Geographic Area in 2024
5.5.8 CAHIC Recent Developments
5.6 HVRI
5.6.1 HVRI Company Information
5.6.2 HVRI Description, Business Overview
5.6.3 HVRI Veterinary Vaccine Products Offered
5.6.4 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 HVRI Veterinary Vaccine Sales by Product in 2024
5.6.6 HVRI Veterinary Vaccine Sales by Application in 2024
5.6.7 HVRI Veterinary Vaccine Sales by Geographic Area in 2024
5.6.8 HVRI Recent Developments
5.7 Ringpu Biology
5.7.1 Ringpu Biology Company Information
5.7.2 Ringpu Biology Description, Business Overview
5.7.3 Ringpu Biology Veterinary Vaccine Products Offered
5.7.4 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Ringpu Biology Veterinary Vaccine Sales by Product in 2024
5.7.6 Ringpu Biology Veterinary Vaccine Sales by Application in 2024
5.7.7 Ringpu Biology Veterinary Vaccine Sales by Geographic Area in 2024
5.7.8 Ringpu Biology Recent Developments
5.8 Yebio
5.8.1 Yebio Company Information
5.8.2 Yebio Description, Business Overview
5.8.3 Yebio Veterinary Vaccine Products Offered
5.8.4 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Yebio Veterinary Vaccine Sales by Product in 2024
5.8.6 Yebio Veterinary Vaccine Sales by Application in 2024
5.8.7 Yebio Veterinary Vaccine Sales by Geographic Area in 2024
5.8.8 Yebio Recent Developments
5.9 DHN
5.9.1 DHN Company Information
5.9.2 DHN Description, Business Overview
5.9.3 DHN Veterinary Vaccine Products Offered
5.9.4 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 DHN Veterinary Vaccine Sales by Product in 2024
5.9.6 DHN Veterinary Vaccine Sales by Application in 2024
5.9.7 DHN Veterinary Vaccine Sales by Geographic Area in 2024
5.9.8 DHN Recent Developments
5.10 WINSUN
5.10.1 WINSUN Company Information
5.10.2 WINSUN Description, Business Overview
5.10.3 WINSUN Veterinary Vaccine Products Offered
5.10.4 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 WINSUN Veterinary Vaccine Sales by Product in 2024
5.10.6 WINSUN Veterinary Vaccine Sales by Application in 2024
5.10.7 WINSUN Veterinary Vaccine Sales by Geographic Area in 2024
5.10.8 WINSUN Recent Developments
5.11 Elanco
5.11.1 Elanco Company Information
5.11.2 Elanco Description, Business Overview
5.11.3 Elanco Veterinary Vaccine Products Offered
5.11.4 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Elanco Veterinary Vaccine Sales by Product in 2024
5.11.6 Elanco Veterinary Vaccine Sales by Application in 2024
5.11.7 Elanco Veterinary Vaccine Sales by Geographic Area in 2024
5.11.8 Elanco Recent Developments
5.12 Virbac
5.12.1 Virbac Company Information
5.12.2 Virbac Description, Business Overview
5.12.3 Virbac Veterinary Vaccine Products Offered
5.12.4 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Virbac Veterinary Vaccine Sales by Product in 2024
5.12.6 Virbac Veterinary Vaccine Sales by Application in 2024
5.12.7 Virbac Veterinary Vaccine Sales by Geographic Area in 2024
5.12.8 Virbac Recent Developments
5.13 Jinyu Bio-Technology
5.13.1 Jinyu Bio-Technology Company Information
5.13.2 Jinyu Bio-Technology Description, Business Overview
5.13.3 Jinyu Bio-Technology Veterinary Vaccine Products Offered
5.13.4 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Jinyu Bio-Technology Veterinary Vaccine Sales by Product in 2024
5.13.6 Jinyu Bio-Technology Veterinary Vaccine Sales by Application in 2024
5.13.7 Jinyu Bio-Technology Veterinary Vaccine Sales by Geographic Area in 2024
5.13.8 Jinyu Bio-Technology Recent Developments
5.14 Medion
5.14.1 Medion Company Information
5.14.2 Medion Description, Business Overview
5.14.3 Medion Veterinary Vaccine Products Offered
5.14.4 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Medion Veterinary Vaccine Sales by Product in 2024
5.14.6 Medion Veterinary Vaccine Sales by Application in 2024
5.14.7 Medion Veterinary Vaccine Sales by Geographic Area in 2024
5.14.8 Medion Recent Developments
5.15 CAVAC
5.15.1 CAVAC Company Information
5.15.2 CAVAC Description, Business Overview
5.15.3 CAVAC Veterinary Vaccine Products Offered
5.15.4 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.15.5 CAVAC Veterinary Vaccine Sales by Product in 2024
5.15.6 CAVAC Veterinary Vaccine Sales by Application in 2024
5.15.7 CAVAC Veterinary Vaccine Sales by Geographic Area in 2024
5.15.8 CAVAC Recent Developments
5.16 Kyoto Biken Laboratories
5.16.1 Kyoto Biken Laboratories Company Information
5.16.2 Kyoto Biken Laboratories Description, Business Overview
5.16.3 Kyoto Biken Laboratories Veterinary Vaccine Products Offered
5.16.4 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Kyoto Biken Laboratories Veterinary Vaccine Sales by Product in 2024
5.16.6 Kyoto Biken Laboratories Veterinary Vaccine Sales by Application in 2024
5.16.7 Kyoto Biken Laboratories Veterinary Vaccine Sales by Geographic Area in 2024
5.16.8 Kyoto Biken Laboratories Recent Developments
5.17 FATRO
5.17.1 FATRO Company Information
5.17.2 FATRO Description, Business Overview
5.17.3 FATRO Veterinary Vaccine Products Offered
5.17.4 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.17.5 FATRO Veterinary Vaccine Sales by Product in 2024
5.17.6 FATRO Veterinary Vaccine Sales by Application in 2024
5.17.7 FATRO Veterinary Vaccine Sales by Geographic Area in 2024
5.17.8 FATRO Recent Developments
5.18 Vaksindo
5.18.1 Vaksindo Company Information
5.18.2 Vaksindo Description, Business Overview
5.18.3 Vaksindo Veterinary Vaccine Products Offered
5.18.4 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Vaksindo Veterinary Vaccine Sales by Product in 2024
5.18.6 Vaksindo Veterinary Vaccine Sales by Application in 2024
5.18.7 Vaksindo Veterinary Vaccine Sales by Geographic Area in 2024
5.18.8 Vaksindo Recent Developments
5.19 Bio-Labs
5.19.1 Bio-Labs Company Information
5.19.2 Bio-Labs Description, Business Overview
5.19.3 Bio-Labs Veterinary Vaccine Products Offered
5.19.4 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Bio-Labs Veterinary Vaccine Sales by Product in 2024
5.19.6 Bio-Labs Veterinary Vaccine Sales by Application in 2024
5.19.7 Bio-Labs Veterinary Vaccine Sales by Geographic Area in 2024
5.19.8 Bio-Labs Recent Developments
5.20 Avimex Animal Health
5.20.1 Avimex Animal Health Company Information
5.20.2 Avimex Animal Health Description, Business Overview
5.20.3 Avimex Animal Health Veterinary Vaccine Products Offered
5.20.4 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.20.5 Avimex Animal Health Veterinary Vaccine Sales by Product in 2024
5.20.6 Avimex Animal Health Veterinary Vaccine Sales by Application in 2024
5.20.7 Avimex Animal Health Veterinary Vaccine Sales by Geographic Area in 2024
5.20.8 Avimex Animal Health Recent Developments
5.21 MEVAC
5.21.1 MEVAC Company Information
5.21.2 MEVAC Description, Business Overview
5.21.3 MEVAC Veterinary Vaccine Products Offered
5.21.4 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.21.5 MEVAC Veterinary Vaccine Sales by Product in 2024
5.21.6 MEVAC Veterinary Vaccine Sales by Application in 2024
5.21.7 MEVAC Veterinary Vaccine Sales by Geographic Area in 2024
5.21.8 MEVAC Recent Developments
5.22 Biovac
5.22.1 Biovac Company Information
5.22.2 Biovac Description, Business Overview
5.22.3 Biovac Veterinary Vaccine Products Offered
5.22.4 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.22.5 Biovac Veterinary Vaccine Sales by Product in 2024
5.22.6 Biovac Veterinary Vaccine Sales by Application in 2024
5.22.7 Biovac Veterinary Vaccine Sales by Geographic Area in 2024
5.22.8 Biovac Recent Developments
5.23 Atafen
5.23.1 Atafen Company Information
5.23.2 Atafen Description, Business Overview
5.23.3 Atafen Veterinary Vaccine Products Offered
5.23.4 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.23.5 Atafen Veterinary Vaccine Sales by Product in 2024
5.23.6 Atafen Veterinary Vaccine Sales by Application in 2024
5.23.7 Atafen Veterinary Vaccine Sales by Geographic Area in 2024
5.23.8 Atafen Recent Developments
5.24 Dyntec
5.24.1 Dyntec Company Information
5.24.2 Dyntec Description, Business Overview
5.24.3 Dyntec Veterinary Vaccine Products Offered
5.24.4 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.24.5 Dyntec Veterinary Vaccine Sales by Product in 2024
5.24.6 Dyntec Veterinary Vaccine Sales by Application in 2024
5.24.7 Dyntec Veterinary Vaccine Sales by Geographic Area in 2024
5.24.8 Dyntec Recent Developments
5.25 RVSRI
5.25.1 RVSRI Company Information
5.25.2 RVSRI Description, Business Overview
5.25.3 RVSRI Veterinary Vaccine Products Offered
5.25.4 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.25.5 RVSRI Veterinary Vaccine Sales by Product in 2024
5.25.6 RVSRI Veterinary Vaccine Sales by Application in 2024
5.25.7 RVSRI Veterinary Vaccine Sales by Geographic Area in 2024
5.25.8 RVSRI Recent Developments
6 North America
6.1 North America Veterinary Vaccine Market Size YoY Growth 2020-2031
6.2 North America Veterinary Vaccine Market Facts & Figures by Country
6.2.1 North America Veterinary Vaccine Sales by Country (2020-2031)
6.2.2 North America Veterinary Vaccine Revenue by Country (2020-2031)
6.3 North America Veterinary Vaccine Sales by Type (2020-2025)
6.4 North America Veterinary Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Veterinary Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Veterinary Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Veterinary Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Veterinary Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Veterinary Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Veterinary Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Veterinary Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Veterinary Vaccine Market Facts & Figures by Country
8.2.1 Europe Veterinary Vaccine Sales by Country (2020-2031)
8.2.2 Europe Veterinary Vaccine Revenue by Country (2020-2031)
8.3 Europe Veterinary Vaccine Sales by Type (2020-2025)
8.4 Europe Veterinary Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Veterinary Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Veterinary Vaccine Market Facts & Figures by Country
9.2.1 Latin America Veterinary Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Veterinary Vaccine Revenue by Country (2020-2031)
9.3 Latin America Veterinary Vaccine Sales by Type (2020-2025)
9.4 Latin America Veterinary Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Veterinary Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Veterinary Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Veterinary Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Veterinary Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Veterinary Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Veterinary Vaccine Supply Chain Analysis
11.2 Veterinary Vaccine Key Raw Materials and Upstream Suppliers
11.3 Veterinary Vaccine Clients Analysis
11.4 Veterinary Vaccine Sales Channel and Sales Model Analysis
11.4.1 Veterinary Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Veterinary Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Veterinary Vaccine Distributors
12 Veterinary Vaccine Market Dynamics
12.1 Veterinary Vaccine Industry Trends
12.2 Veterinary Vaccine Market Drivers
12.3 Veterinary Vaccine Market Challenges
12.4 Veterinary Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Veterinary Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Veterinary Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Veterinary Vaccine Sales by Region (2020-2025) & (M Doses)
Table 5. Global Veterinary Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Veterinary Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Veterinary Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Veterinary Vaccine Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Veterinary Vaccine Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Veterinary Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Veterinary Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Veterinary Vaccine Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Veterinary Vaccine Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Veterinary Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Veterinary Vaccine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Veterinary Vaccine Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Veterinary Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Veterinary Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Veterinary Vaccine Price (2020-2025) & (USD/K Doses)
Table 21. Ranking of Global Top Veterinary Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2024)
Table 24. Veterinary Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Veterinary Vaccine Market
Table 26. Manufacturers Veterinary Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Merck Company Information
Table 29. Merck Description and Business Overview
Table 30. Merck Veterinary Vaccine Product
Table 31. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 32. Merck Sales Proportion of Veterinary Vaccine by Product in 2024
Table 33. Merck Sales Proportion of Veterinary Vaccine by Application in 2024
Table 34. Merck Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 35. Merck Recent Developments
Table 36. Zoetis Company Information
Table 37. Zoetis Description and Business Overview
Table 38. Zoetis Veterinary Vaccine Product
Table 39. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 40. Zoetis Sales Proportion of Veterinary Vaccine by Product in 2024
Table 41. Zoetis Sales Proportion of Veterinary Vaccine by Application in 2024
Table 42. Zoetis Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 43. Zoetis Recent Developments
Table 44. Boehringer Ingelheim Company Information
Table 45. Boehringer Ingelheim Description and Business Overview
Table 46. Boehringer Ingelheim Veterinary Vaccine Product
Table 47. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 48. Boehringer Ingelheim Sales Proportion of Veterinary Vaccine by Product in 2024
Table 49. Boehringer Ingelheim Sales Proportion of Veterinary Vaccine by Application in 2024
Table 50. Boehringer Ingelheim Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 51. Boehringer Ingelheim Recent Developments
Table 52. Ceva Company Information
Table 53. Ceva Description and Business Overview
Table 54. Ceva Veterinary Vaccine Product
Table 55. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 56. Ceva Sales Proportion of Veterinary Vaccine by Product in 2024
Table 57. Ceva Sales Proportion of Veterinary Vaccine by Application in 2024
Table 58. Ceva Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 59. Ceva Recent Developments
Table 60. CAHIC Company Information
Table 61. CAHIC Description and Business Overview
Table 62. CAHIC Veterinary Vaccine Product
Table 63. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 64. CAHIC Sales Proportion of Veterinary Vaccine by Product in 2024
Table 65. CAHIC Sales Proportion of Veterinary Vaccine by Application in 2024
Table 66. CAHIC Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 67. CAHIC Recent Developments
Table 68. HVRI Company Information
Table 69. HVRI Description and Business Overview
Table 70. HVRI Veterinary Vaccine Product
Table 71. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 72. HVRI Sales Proportion of Veterinary Vaccine by Product in 2024
Table 73. HVRI Sales Proportion of Veterinary Vaccine by Application in 2024
Table 74. HVRI Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 75. HVRI Recent Developments
Table 76. Ringpu Biology Company Information
Table 77. Ringpu Biology Description and Business Overview
Table 78. Ringpu Biology Veterinary Vaccine Product
Table 79. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Ringpu Biology Sales Proportion of Veterinary Vaccine by Product in 2024
Table 81. Ringpu Biology Sales Proportion of Veterinary Vaccine by Application in 2024
Table 82. Ringpu Biology Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 83. Ringpu Biology Recent Developments
Table 84. Yebio Company Information
Table 85. Yebio Description and Business Overview
Table 86. Yebio Veterinary Vaccine Product
Table 87. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Yebio Sales Proportion of Veterinary Vaccine by Product in 2024
Table 89. Yebio Sales Proportion of Veterinary Vaccine by Application in 2024
Table 90. Yebio Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 91. Yebio Recent Developments
Table 92. DHN Company Information
Table 93. DHN Description and Business Overview
Table 94. DHN Veterinary Vaccine Product
Table 95. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. DHN Sales Proportion of Veterinary Vaccine by Product in 2024
Table 97. DHN Sales Proportion of Veterinary Vaccine by Application in 2024
Table 98. DHN Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 99. DHN Recent Developments
Table 100. WINSUN Company Information
Table 101. WINSUN Description and Business Overview
Table 102. WINSUN Veterinary Vaccine Product
Table 103. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 104. WINSUN Sales Proportion of Veterinary Vaccine by Product in 2024
Table 105. WINSUN Sales Proportion of Veterinary Vaccine by Application in 2024
Table 106. WINSUN Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 107. WINSUN Recent Developments
Table 108. Elanco Company Information
Table 109. Elanco Description and Business Overview
Table 110. Elanco Veterinary Vaccine Product
Table 111. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 112. Elanco Sales Proportion of Veterinary Vaccine by Product in 2024
Table 113. Elanco Sales Proportion of Veterinary Vaccine by Application in 2024
Table 114. Elanco Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 115. Elanco Recent Developments
Table 116. Virbac Company Information
Table 117. Virbac Description and Business Overview
Table 118. Virbac Veterinary Vaccine Product
Table 119. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Virbac Sales Proportion of Veterinary Vaccine by Product in 2024
Table 121. Virbac Sales Proportion of Veterinary Vaccine by Application in 2024
Table 122. Virbac Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 123. Virbac Recent Developments
Table 124. Jinyu Bio-Technology Company Information
Table 125. Jinyu Bio-Technology Description and Business Overview
Table 126. Jinyu Bio-Technology Veterinary Vaccine Product
Table 127. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. Jinyu Bio-Technology Sales Proportion of Veterinary Vaccine by Product in 2024
Table 129. Jinyu Bio-Technology Sales Proportion of Veterinary Vaccine by Application in 2024
Table 130. Jinyu Bio-Technology Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 131. Jinyu Bio-Technology Recent Developments
Table 132. Medion Company Information
Table 133. Medion Description and Business Overview
Table 134. Medion Veterinary Vaccine Product
Table 135. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. Medion Sales Proportion of Veterinary Vaccine by Product in 2024
Table 137. Medion Sales Proportion of Veterinary Vaccine by Application in 2024
Table 138. Medion Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 139. Medion Recent Developments
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Veterinary Vaccine Product
Table 143. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 144. CAVAC Sales Proportion of Veterinary Vaccine by Product in 2024
Table 145. CAVAC Sales Proportion of Veterinary Vaccine by Application in 2024
Table 146. CAVAC Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 147. CAVAC Recent Developments
Table 148. Kyoto Biken Laboratories Company Information
Table 149. Kyoto Biken Laboratories Description and Business Overview
Table 150. Kyoto Biken Laboratories Veterinary Vaccine Product
Table 151. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 152. Kyoto Biken Laboratories Sales Proportion of Veterinary Vaccine by Product in 2024
Table 153. Kyoto Biken Laboratories Sales Proportion of Veterinary Vaccine by Application in 2024
Table 154. Kyoto Biken Laboratories Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 155. Kyoto Biken Laboratories Recent Developments
Table 156. FATRO Company Information
Table 157. FATRO Description and Business Overview
Table 158. FATRO Veterinary Vaccine Product
Table 159. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. FATRO Sales Proportion of Veterinary Vaccine by Product in 2024
Table 161. FATRO Sales Proportion of Veterinary Vaccine by Application in 2024
Table 162. FATRO Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 163. FATRO Recent Developments
Table 164. Vaksindo Company Information
Table 165. Vaksindo Description and Business Overview
Table 166. Vaksindo Veterinary Vaccine Product
Table 167. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Vaksindo Sales Proportion of Veterinary Vaccine by Product in 2024
Table 169. Vaksindo Sales Proportion of Veterinary Vaccine by Application in 2024
Table 170. Vaksindo Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 171. Vaksindo Recent Developments
Table 172. Bio-Labs Company Information
Table 173. Bio-Labs Description and Business Overview
Table 174. Bio-Labs Veterinary Vaccine Product
Table 175. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 176. Bio-Labs Sales Proportion of Veterinary Vaccine by Product in 2024
Table 177. Bio-Labs Sales Proportion of Veterinary Vaccine by Application in 2024
Table 178. Bio-Labs Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 179. Bio-Labs Recent Developments
Table 180. Avimex Animal Health Company Information
Table 181. Avimex Animal Health Description and Business Overview
Table 182. Avimex Animal Health Veterinary Vaccine Product
Table 183. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 184. Avimex Animal Health Sales Proportion of Veterinary Vaccine by Product in 2024
Table 185. Avimex Animal Health Sales Proportion of Veterinary Vaccine by Application in 2024
Table 186. Avimex Animal Health Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 187. Avimex Animal Health Recent Developments
Table 188. MEVAC Company Information
Table 189. MEVAC Description and Business Overview
Table 190. MEVAC Veterinary Vaccine Product
Table 191. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 192. MEVAC Sales Proportion of Veterinary Vaccine by Product in 2024
Table 193. MEVAC Sales Proportion of Veterinary Vaccine by Application in 2024
Table 194. MEVAC Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 195. MEVAC Recent Developments
Table 196. Biovac Company Information
Table 197. Biovac Description and Business Overview
Table 198. Biovac Veterinary Vaccine Product
Table 199. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 200. Biovac Sales Proportion of Veterinary Vaccine by Product in 2024
Table 201. Biovac Sales Proportion of Veterinary Vaccine by Application in 2024
Table 202. Biovac Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 203. Biovac Recent Developments
Table 204. Atafen Company Information
Table 205. Atafen Description and Business Overview
Table 206. Atafen Veterinary Vaccine Product
Table 207. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 208. Atafen Sales Proportion of Veterinary Vaccine by Product in 2024
Table 209. Atafen Sales Proportion of Veterinary Vaccine by Application in 2024
Table 210. Atafen Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 211. Atafen Recent Developments
Table 212. Dyntec Company Information
Table 213. Dyntec Description and Business Overview
Table 214. Dyntec Veterinary Vaccine Product
Table 215. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 216. Dyntec Sales Proportion of Veterinary Vaccine by Product in 2024
Table 217. Dyntec Sales Proportion of Veterinary Vaccine by Application in 2024
Table 218. Dyntec Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 219. Dyntec Recent Developments
Table 220. RVSRI Company Information
Table 221. RVSRI Description and Business Overview
Table 222. RVSRI Veterinary Vaccine Product
Table 223. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 224. RVSRI Sales Proportion of Veterinary Vaccine by Product in 2024
Table 225. RVSRI Sales Proportion of Veterinary Vaccine by Application in 2024
Table 226. RVSRI Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 227. RVSRI Recent Developments
Table 228. North America Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 229. North America Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 230. North America Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 231. North America Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 232. North America Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 233. North America Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 234. Asia-Pacific Veterinary Vaccine Sales by Region (2020-2025) & (M Doses)
Table 235. Asia-Pacific Veterinary Vaccine Sales by Region (2026-2031) & (M Doses)
Table 236. Asia-Pacific Veterinary Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 237. Asia-Pacific Veterinary Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 238. Asia-Pacific Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 239. Asia-Pacific Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 240. Europe Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 241. Europe Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 242. Europe Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 243. Europe Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 244. Europe Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 245. Europe Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 246. Latin America Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 247. Latin America Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 248. Latin America Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 249. Latin America Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 250. Latin America Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 251. Latin America Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 252. Middle East and Africa Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 253. Middle East and Africa Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 254. Middle East and Africa Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 255. Middle East and Africa Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 256. Middle East and Africa Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 257. Middle East and Africa Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 258. Veterinary Vaccine Key Raw Materials, Industry Status and Trend
Table 259. Veterinary Vaccine Key Raw Materials and Upstream Suppliers
Table 260. Veterinary Vaccine Clients Status and Trend
Table 261. Veterinary Vaccine Typical Clients
Table 262. Veterinary Vaccine Distributors
Table 263. Veterinary Vaccine Market Trends
Table 264. Veterinary Vaccine Market Drivers
Table 265. Veterinary Vaccine Market Challenges
Table 266. Veterinary Vaccine Market Restraints
Table 267. Research Programs/Design for This Report
Table 268. Key Data Information from Secondary Sources
Table 269. Key Data Information from Primary Sources
Table 270. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Veterinary Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Other Product Picture
Figure 7. Global Veterinary Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Veterinary Vaccine Sales Market Share by Application in 2024 & 2031
Figure 9. Farm Animal
Figure 10. Companion Animal
Figure 11. Veterinary Vaccine Report Years Considered
Figure 12. Global Veterinary Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Veterinary Vaccine Market Size 2020-2031 (US$ Million)
Figure 14. Global Veterinary Vaccine Sales 2020-2031 (M Doses)
Figure 15. Global Veterinary Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Veterinary Vaccine Revenue Market Share by Region (2020-2031)
Figure 17. Global Veterinary Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Veterinary Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/K Doses)
Figure 20. Global Veterinary Vaccine Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Veterinary Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/K Doses)
Figure 23. Live Attenuated Vaccines of Veterinary Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Inactivated Vaccines of Veterinary Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Other of Veterinary Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Veterinary Vaccine Sales Share by Manufacturer in 2024
Figure 27. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Live Attenuated Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 29. Inactivated Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 30. Other Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Veterinary Vaccine Revenue 2020-2031 (US$ Million)
Figure 32. North America Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 33. North America Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Veterinary Vaccine Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Veterinary Vaccine Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Veterinary Vaccine Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 39. Europe Veterinary Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Veterinary Vaccine Sales Market Share by Country (2020-2031)
Figure 41. Europe Veterinary Vaccine Revenue Market Share by Country (2020-2031)
Figure 42. Europe Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 43. Europe Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 44. Latin America Veterinary Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Veterinary Vaccine Sales Market Share by Country (2020-2031)
Figure 46. Latin America Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 48. Latin America Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Veterinary Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Veterinary Vaccine Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 54. Veterinary Vaccine Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Veterinary Vaccine Raw Materials by Region in 2024
Figure 56. Veterinary Vaccine Distribution Channels
Figure 57. Global Veterinary Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Veterinary Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Veterinary Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Veterinary Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Veterinary Vaccine Sales by Region (2020-2025) & (M Doses)
Table 5. Global Veterinary Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Veterinary Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Veterinary Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Veterinary Vaccine Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Veterinary Vaccine Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Veterinary Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Veterinary Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Veterinary Vaccine Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Veterinary Vaccine Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Veterinary Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Veterinary Vaccine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Veterinary Vaccine Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Veterinary Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Veterinary Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Veterinary Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Veterinary Vaccine Price (2020-2025) & (USD/K Doses)
Table 21. Ranking of Global Top Veterinary Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2024)
Table 24. Veterinary Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Veterinary Vaccine Market
Table 26. Manufacturers Veterinary Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Merck Company Information
Table 29. Merck Description and Business Overview
Table 30. Merck Veterinary Vaccine Product
Table 31. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 32. Merck Sales Proportion of Veterinary Vaccine by Product in 2024
Table 33. Merck Sales Proportion of Veterinary Vaccine by Application in 2024
Table 34. Merck Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 35. Merck Recent Developments
Table 36. Zoetis Company Information
Table 37. Zoetis Description and Business Overview
Table 38. Zoetis Veterinary Vaccine Product
Table 39. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 40. Zoetis Sales Proportion of Veterinary Vaccine by Product in 2024
Table 41. Zoetis Sales Proportion of Veterinary Vaccine by Application in 2024
Table 42. Zoetis Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 43. Zoetis Recent Developments
Table 44. Boehringer Ingelheim Company Information
Table 45. Boehringer Ingelheim Description and Business Overview
Table 46. Boehringer Ingelheim Veterinary Vaccine Product
Table 47. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 48. Boehringer Ingelheim Sales Proportion of Veterinary Vaccine by Product in 2024
Table 49. Boehringer Ingelheim Sales Proportion of Veterinary Vaccine by Application in 2024
Table 50. Boehringer Ingelheim Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 51. Boehringer Ingelheim Recent Developments
Table 52. Ceva Company Information
Table 53. Ceva Description and Business Overview
Table 54. Ceva Veterinary Vaccine Product
Table 55. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 56. Ceva Sales Proportion of Veterinary Vaccine by Product in 2024
Table 57. Ceva Sales Proportion of Veterinary Vaccine by Application in 2024
Table 58. Ceva Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 59. Ceva Recent Developments
Table 60. CAHIC Company Information
Table 61. CAHIC Description and Business Overview
Table 62. CAHIC Veterinary Vaccine Product
Table 63. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 64. CAHIC Sales Proportion of Veterinary Vaccine by Product in 2024
Table 65. CAHIC Sales Proportion of Veterinary Vaccine by Application in 2024
Table 66. CAHIC Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 67. CAHIC Recent Developments
Table 68. HVRI Company Information
Table 69. HVRI Description and Business Overview
Table 70. HVRI Veterinary Vaccine Product
Table 71. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 72. HVRI Sales Proportion of Veterinary Vaccine by Product in 2024
Table 73. HVRI Sales Proportion of Veterinary Vaccine by Application in 2024
Table 74. HVRI Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 75. HVRI Recent Developments
Table 76. Ringpu Biology Company Information
Table 77. Ringpu Biology Description and Business Overview
Table 78. Ringpu Biology Veterinary Vaccine Product
Table 79. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Ringpu Biology Sales Proportion of Veterinary Vaccine by Product in 2024
Table 81. Ringpu Biology Sales Proportion of Veterinary Vaccine by Application in 2024
Table 82. Ringpu Biology Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 83. Ringpu Biology Recent Developments
Table 84. Yebio Company Information
Table 85. Yebio Description and Business Overview
Table 86. Yebio Veterinary Vaccine Product
Table 87. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Yebio Sales Proportion of Veterinary Vaccine by Product in 2024
Table 89. Yebio Sales Proportion of Veterinary Vaccine by Application in 2024
Table 90. Yebio Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 91. Yebio Recent Developments
Table 92. DHN Company Information
Table 93. DHN Description and Business Overview
Table 94. DHN Veterinary Vaccine Product
Table 95. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 96. DHN Sales Proportion of Veterinary Vaccine by Product in 2024
Table 97. DHN Sales Proportion of Veterinary Vaccine by Application in 2024
Table 98. DHN Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 99. DHN Recent Developments
Table 100. WINSUN Company Information
Table 101. WINSUN Description and Business Overview
Table 102. WINSUN Veterinary Vaccine Product
Table 103. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 104. WINSUN Sales Proportion of Veterinary Vaccine by Product in 2024
Table 105. WINSUN Sales Proportion of Veterinary Vaccine by Application in 2024
Table 106. WINSUN Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 107. WINSUN Recent Developments
Table 108. Elanco Company Information
Table 109. Elanco Description and Business Overview
Table 110. Elanco Veterinary Vaccine Product
Table 111. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 112. Elanco Sales Proportion of Veterinary Vaccine by Product in 2024
Table 113. Elanco Sales Proportion of Veterinary Vaccine by Application in 2024
Table 114. Elanco Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 115. Elanco Recent Developments
Table 116. Virbac Company Information
Table 117. Virbac Description and Business Overview
Table 118. Virbac Veterinary Vaccine Product
Table 119. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Virbac Sales Proportion of Veterinary Vaccine by Product in 2024
Table 121. Virbac Sales Proportion of Veterinary Vaccine by Application in 2024
Table 122. Virbac Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 123. Virbac Recent Developments
Table 124. Jinyu Bio-Technology Company Information
Table 125. Jinyu Bio-Technology Description and Business Overview
Table 126. Jinyu Bio-Technology Veterinary Vaccine Product
Table 127. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. Jinyu Bio-Technology Sales Proportion of Veterinary Vaccine by Product in 2024
Table 129. Jinyu Bio-Technology Sales Proportion of Veterinary Vaccine by Application in 2024
Table 130. Jinyu Bio-Technology Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 131. Jinyu Bio-Technology Recent Developments
Table 132. Medion Company Information
Table 133. Medion Description and Business Overview
Table 134. Medion Veterinary Vaccine Product
Table 135. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 136. Medion Sales Proportion of Veterinary Vaccine by Product in 2024
Table 137. Medion Sales Proportion of Veterinary Vaccine by Application in 2024
Table 138. Medion Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 139. Medion Recent Developments
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Veterinary Vaccine Product
Table 143. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 144. CAVAC Sales Proportion of Veterinary Vaccine by Product in 2024
Table 145. CAVAC Sales Proportion of Veterinary Vaccine by Application in 2024
Table 146. CAVAC Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 147. CAVAC Recent Developments
Table 148. Kyoto Biken Laboratories Company Information
Table 149. Kyoto Biken Laboratories Description and Business Overview
Table 150. Kyoto Biken Laboratories Veterinary Vaccine Product
Table 151. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 152. Kyoto Biken Laboratories Sales Proportion of Veterinary Vaccine by Product in 2024
Table 153. Kyoto Biken Laboratories Sales Proportion of Veterinary Vaccine by Application in 2024
Table 154. Kyoto Biken Laboratories Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 155. Kyoto Biken Laboratories Recent Developments
Table 156. FATRO Company Information
Table 157. FATRO Description and Business Overview
Table 158. FATRO Veterinary Vaccine Product
Table 159. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. FATRO Sales Proportion of Veterinary Vaccine by Product in 2024
Table 161. FATRO Sales Proportion of Veterinary Vaccine by Application in 2024
Table 162. FATRO Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 163. FATRO Recent Developments
Table 164. Vaksindo Company Information
Table 165. Vaksindo Description and Business Overview
Table 166. Vaksindo Veterinary Vaccine Product
Table 167. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 168. Vaksindo Sales Proportion of Veterinary Vaccine by Product in 2024
Table 169. Vaksindo Sales Proportion of Veterinary Vaccine by Application in 2024
Table 170. Vaksindo Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 171. Vaksindo Recent Developments
Table 172. Bio-Labs Company Information
Table 173. Bio-Labs Description and Business Overview
Table 174. Bio-Labs Veterinary Vaccine Product
Table 175. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 176. Bio-Labs Sales Proportion of Veterinary Vaccine by Product in 2024
Table 177. Bio-Labs Sales Proportion of Veterinary Vaccine by Application in 2024
Table 178. Bio-Labs Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 179. Bio-Labs Recent Developments
Table 180. Avimex Animal Health Company Information
Table 181. Avimex Animal Health Description and Business Overview
Table 182. Avimex Animal Health Veterinary Vaccine Product
Table 183. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 184. Avimex Animal Health Sales Proportion of Veterinary Vaccine by Product in 2024
Table 185. Avimex Animal Health Sales Proportion of Veterinary Vaccine by Application in 2024
Table 186. Avimex Animal Health Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 187. Avimex Animal Health Recent Developments
Table 188. MEVAC Company Information
Table 189. MEVAC Description and Business Overview
Table 190. MEVAC Veterinary Vaccine Product
Table 191. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 192. MEVAC Sales Proportion of Veterinary Vaccine by Product in 2024
Table 193. MEVAC Sales Proportion of Veterinary Vaccine by Application in 2024
Table 194. MEVAC Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 195. MEVAC Recent Developments
Table 196. Biovac Company Information
Table 197. Biovac Description and Business Overview
Table 198. Biovac Veterinary Vaccine Product
Table 199. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 200. Biovac Sales Proportion of Veterinary Vaccine by Product in 2024
Table 201. Biovac Sales Proportion of Veterinary Vaccine by Application in 2024
Table 202. Biovac Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 203. Biovac Recent Developments
Table 204. Atafen Company Information
Table 205. Atafen Description and Business Overview
Table 206. Atafen Veterinary Vaccine Product
Table 207. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 208. Atafen Sales Proportion of Veterinary Vaccine by Product in 2024
Table 209. Atafen Sales Proportion of Veterinary Vaccine by Application in 2024
Table 210. Atafen Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 211. Atafen Recent Developments
Table 212. Dyntec Company Information
Table 213. Dyntec Description and Business Overview
Table 214. Dyntec Veterinary Vaccine Product
Table 215. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 216. Dyntec Sales Proportion of Veterinary Vaccine by Product in 2024
Table 217. Dyntec Sales Proportion of Veterinary Vaccine by Application in 2024
Table 218. Dyntec Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 219. Dyntec Recent Developments
Table 220. RVSRI Company Information
Table 221. RVSRI Description and Business Overview
Table 222. RVSRI Veterinary Vaccine Product
Table 223. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 224. RVSRI Sales Proportion of Veterinary Vaccine by Product in 2024
Table 225. RVSRI Sales Proportion of Veterinary Vaccine by Application in 2024
Table 226. RVSRI Sales Proportion of Veterinary Vaccine by Geographic Area in 2024
Table 227. RVSRI Recent Developments
Table 228. North America Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 229. North America Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 230. North America Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 231. North America Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 232. North America Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 233. North America Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 234. Asia-Pacific Veterinary Vaccine Sales by Region (2020-2025) & (M Doses)
Table 235. Asia-Pacific Veterinary Vaccine Sales by Region (2026-2031) & (M Doses)
Table 236. Asia-Pacific Veterinary Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 237. Asia-Pacific Veterinary Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 238. Asia-Pacific Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 239. Asia-Pacific Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 240. Europe Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 241. Europe Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 242. Europe Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 243. Europe Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 244. Europe Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 245. Europe Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 246. Latin America Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 247. Latin America Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 248. Latin America Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 249. Latin America Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 250. Latin America Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 251. Latin America Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 252. Middle East and Africa Veterinary Vaccine Sales by Country (2020-2025) & (M Doses)
Table 253. Middle East and Africa Veterinary Vaccine Sales by Country (2026-2031) & (M Doses)
Table 254. Middle East and Africa Veterinary Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 255. Middle East and Africa Veterinary Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 256. Middle East and Africa Veterinary Vaccine Sales by Type (2020-2025) & (M Doses)
Table 257. Middle East and Africa Veterinary Vaccine Sales by Application (2020-2025) & (M Doses)
Table 258. Veterinary Vaccine Key Raw Materials, Industry Status and Trend
Table 259. Veterinary Vaccine Key Raw Materials and Upstream Suppliers
Table 260. Veterinary Vaccine Clients Status and Trend
Table 261. Veterinary Vaccine Typical Clients
Table 262. Veterinary Vaccine Distributors
Table 263. Veterinary Vaccine Market Trends
Table 264. Veterinary Vaccine Market Drivers
Table 265. Veterinary Vaccine Market Challenges
Table 266. Veterinary Vaccine Market Restraints
Table 267. Research Programs/Design for This Report
Table 268. Key Data Information from Secondary Sources
Table 269. Key Data Information from Primary Sources
Table 270. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Veterinary Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Other Product Picture
Figure 7. Global Veterinary Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Veterinary Vaccine Sales Market Share by Application in 2024 & 2031
Figure 9. Farm Animal
Figure 10. Companion Animal
Figure 11. Veterinary Vaccine Report Years Considered
Figure 12. Global Veterinary Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Veterinary Vaccine Market Size 2020-2031 (US$ Million)
Figure 14. Global Veterinary Vaccine Sales 2020-2031 (M Doses)
Figure 15. Global Veterinary Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Veterinary Vaccine Revenue Market Share by Region (2020-2031)
Figure 17. Global Veterinary Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Veterinary Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/K Doses)
Figure 20. Global Veterinary Vaccine Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Veterinary Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/K Doses)
Figure 23. Live Attenuated Vaccines of Veterinary Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Inactivated Vaccines of Veterinary Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Other of Veterinary Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Veterinary Vaccine Sales Share by Manufacturer in 2024
Figure 27. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Live Attenuated Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 29. Inactivated Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 30. Other Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Veterinary Vaccine Revenue 2020-2031 (US$ Million)
Figure 32. North America Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 33. North America Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Veterinary Vaccine Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Veterinary Vaccine Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Veterinary Vaccine Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 39. Europe Veterinary Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Veterinary Vaccine Sales Market Share by Country (2020-2031)
Figure 41. Europe Veterinary Vaccine Revenue Market Share by Country (2020-2031)
Figure 42. Europe Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 43. Europe Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 44. Latin America Veterinary Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Veterinary Vaccine Sales Market Share by Country (2020-2031)
Figure 46. Latin America Veterinary Vaccine Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 48. Latin America Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Veterinary Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Veterinary Vaccine Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Veterinary Vaccine Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Veterinary Vaccine Sales Market Share by Application (2020-2025)
Figure 54. Veterinary Vaccine Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Veterinary Vaccine Raw Materials by Region in 2024
Figure 56. Veterinary Vaccine Distribution Channels
Figure 57. Global Veterinary Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Veterinary Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232